Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

GlaxoSmithKline PLC ADR (GSK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow GlaxoSmithKline ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
40.18 +0.37    +0.93%
26/10 - Closed. Currency in USD ( Disclaimer )
After Hours
39.75
-0.43
-1.07%
0:57:21 - Real-time Data
  • Volume: 4,959,705
  • Bid/Ask: 39.75 / 39.95
  • Day's Range: 39.86 - 40.21
Type:  Equity
Market:  United States
ISIN:  US37733W1053 
CUSIP:  37733W105
GlaxoSmithKline ADR 40.18 +0.37 +0.93%
Period Ending: 2021
30/06
2021
31/03
2020
31/12
2020
30/09
Total Current Assets 17566 18524 20247 19881
Cash and Short Term Investments 3562 4817 6370 4366
Cash - - - -
Cash & Equivalents 3503 4757 6292 4283
Short Term Investments 59 60 78 83
Total Receivables, Net 7507 7183 7623 8421
Accounts Receivables - Trade, Net 6902 6492 6952 7854
Total Inventory 6330 6216 5996 6440
Prepaid Expenses - - - -
Other Current Assets, Total 167 308 258 654
Total Assets 77011 78079 80431 80927
Property/Plant/Equipment, Total - Net 10589 10633 11006 11205
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 10435 10442 10597 10888
Intangibles, Net 29333 29418 29824 30664
Long Term Investments 3235 3755 3424 2972
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 5853 5307 5333 5317
Other Assets, Total - - - -
Total Current Liabilities 21387 20275 22148 22179
Accounts Payable - - - -
Payable/Accrued 14267 14610 15840 15142
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 5041 3172 3725 4914
Other Current liabilities, Total 2079 2493 2583 2123
Total Liabilities 61634 63214 65844 66641
Total Long Term Debt 20442 23047 23425 23334
Long Term Debt 20442 23047 23425 23334
Capital Lease Obligations - - - -
Deferred Income Tax 3587 3566 3600 3917
Minority Interest 6201 6145 6221 6339
Other Liabilities, Total 10017 10181 10450 10872
Total Equity 15377 14865 14587 14286
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1347 1346 1346 1346
Additional Paid-In Capital 3299 3296 3281 3280
Retained Earnings (Accumulated Deficit) 10731 10223 9960 9660
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - -
Total Liabilities & Shareholders' Equity 77011 78079 80431 80927
Total Common Shares Outstanding 5031.68 5031.39 5029.98 5017.38
Total Preferred Shares Outstanding - - - -
* In Millions of GBP (except for per share items)
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK Comments

Write your thoughts about GlaxoSmithKline PLC ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GSK movie forward. Thanks you
Faruk Mia
Faruk Mia Apr 27, 2021 7:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
হাই
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email